S&P 500
(0.99%) 5 098.37 points
Dow Jones
(0.48%) 38 267 points
Nasdaq
(1.80%) 15 893 points
Oil
(0.53%) $84.01
Gas
(-2.50%) $1.597
Gold
(0.41%) $2 352.10
Silver
(0.54%) $27.50
Platinum
(0.26%) $922.90
USD/EUR
(0.35%) $0.935
USD/NOK
(0.73%) $11.03
USD/GBP
(0.18%) $0.801
USD/RUB
(-0.43%) $91.77

Realtime updates for Coloplast A/S [CLPBY]

Exchange: OTC Sector: Healthcare Industry: Medical Instruments & Supplies
Last Updated26 Apr 2024 @ 09:51

-0.56% $ 12.51

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 09:51):

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally...

Stats
Today's Volume 2 243.00
Average Volume 114 356
Market Cap 29.55B
EPS $0.598 ( 2023-06-30 )
Next earnings date ( $0.0800 ) 2024-05-09
Last Dividend $0.0740 ( 2023-05-19 )
Next Dividend $0 ( N/A )
P/E 41.70
ATR14 $0.0180 (0.14%)

Volume Correlation

Long: 0.05 (neutral)
Short: -0.09 (neutral)
Signal:(43.175) Neutral

Coloplast A/S Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Coloplast A/S Correlation - Currency/Commodity

The country flag 0.79
( moderate )
The country flag 0.82
( strong )
The country flag 0.00
( neutral )
The country flag 0.75
( moderate )
The country flag -0.69
( moderate negative )
The country flag 0.08
( neutral )

Coloplast A/S Financials

Annual 2023
Revenue: $24.50B
Gross Profit: $16.33B (66.64 %)
EPS: $22.21
FY 2023
Revenue: $24.50B
Gross Profit: $16.33B (66.64 %)
EPS: $22.21
FY 2022
Revenue: $22.58B
Gross Profit: $15.53B (68.78 %)
EPS: $22.15
FY 2021
Revenue: $19.43B
Gross Profit: $13.31B (68.53 %)
EPS: $2.27

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0.210
(N/A)
$0
(N/A)
$0.0740
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.57 - average (85.65%) | Divividend Growth Potential Score: 3.18 - Decrease likely (36.46%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0810 2021-05-14
Last Dividend $0.0740 2023-05-19
Next Dividend $0 N/A
Payout Date 2023-05-30
Next Payout Date N/A
# dividends 5 --
Total Paid Out $0.649 --
Avg. Dividend % Per Year 0.00% --
Score 2.51 --
Div. Sustainability Score 6.57
Div.Growth Potential Score 3.18
Div. Directional Score 4.87 --
Next Divdend (Est)
(2024-10-01)
$0.00796 Estimate 3.61 %
Dividend Stability
0.29 Very Poor
Dividend Score
2.51
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
TSRYY Ex Dividend Knight 2023-08-30 Semi-Annually 0 0.00%
JMSB Ex Dividend Junior 2023-06-26 Annually 0 0.00%
BOSSY Ex Dividend Junior 2023-05-10 Annually 0 0.00%
REPYY Ex Dividend Knight 2023-07-03 Annually 0 0.00%
FBTT Ex Dividend Junior 2023-09-21 Quarterly 0 0.00%
VNRFY Ex Dividend Junior 2023-05-30 Annually 0 0.00%
LNVGY Ex Dividend Knight 2023-07-26 Annually 0 0.00%
CKHUY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
SGAPY Ex Dividend Knight 2023-08-02 Semi-Annually 0 0.00%
GNGBY Ex Dividend Junior 2023-04-27 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1951.5006.119.16[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4241.5006.409.60[0.1 - 1]
payoutRatioTTM0.957-1.0000.433-0.433[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.3240.800-2.80-2.24[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM9.311.0007.667.66[3 - 30]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
freeCashFlowPerShareTTM19.612.000.1950.389[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6671.0002.212.21[0.2 - 0.8]
operatingProfitMarginTTM0.2731.0006.536.53[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2561.0009.699.69[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score6.57

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM3.931.0009.700[1 - 100]
returnOnEquityTTM0.4242.507.699.60[0.1 - 1.5]
freeCashFlowPerShareTTM19.612.003.460.389[0 - 30]
dividendYielPercentageTTM0.3511.5001.2270[0 - 0.4]
operatingCashFlowPerShareTTM25.302.001.5683.14[0 - 30]
payoutRatioTTM0.9571.5000.433-0.433[0 - 1]
pegRatioTTM-0.2461.500-4.970[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2211.0006.970[0.1 - 0.5]
Total Score3.18

Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators